Mycobacterium nebraskense as a cause of nodular pulmonary disease

Conn Med. 2011 Oct;75(9):527-9.

Abstract

Mycobacterium nebraskense is a scotochromogenic mycobacterium first isolated from sputum samples of five patients at the University of Nebraska Medical Center. M. nebraskense was first identified as a pathogen in an immunocompetent host, also in Nebraska. In this case report, we describe a patient with nodular pulmonary disease most likely due to M. nebraskense, who was successfully treated with rifampin and azithromycin, representing the first case in which this organism was a pathogen outside of Nebraska and the first description of successful treatment of this infection.

Publication types

  • Case Reports

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Antibiotics, Antitubercular / therapeutic use
  • Azithromycin / therapeutic use
  • Connecticut
  • Diagnosis, Differential
  • Humans
  • Male
  • Middle Aged
  • Mycobacterium Infections, Nontuberculous / diagnosis*
  • Mycobacterium Infections, Nontuberculous / drug therapy
  • Mycobacterium Infections, Nontuberculous / microbiology*
  • Nontuberculous Mycobacteria / isolation & purification*
  • Rifampin / therapeutic use
  • Sputum / microbiology
  • Stents
  • Tomography, X-Ray Computed

Substances

  • Anti-Bacterial Agents
  • Antibiotics, Antitubercular
  • Azithromycin
  • Rifampin